Aurinia shareholders elect all nine board nominees and approve auditor and say-on-pay at 2022 annual meeting

Aurinia Pharmaceuticals Inc.

All nine director nominees elected; for votes ranged from 24.1M (Hagan) to 34.3M (Balakrishnan); broker non-votes 27.9M.
PricewaterhouseCoopers ratified as independent auditor: 63.3M for, 6.7M against, 2.0M abstain.
Say-on-pay advisory resolution approved: 33.1M for, 10.5M against, 0.6M abstain; 27.9M broker non-votes.
Meeting held virtually on May 17, 2022; results reported on May 20, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.